X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare IPCA Labs with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs J.B.CHEMICALS - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS J.B.CHEMICALS IPCA LABS/
J.B.CHEMICALS
 
P/E (TTM) x 27.8 13.9 200.1% View Chart
P/BV x 2.1 2.2 97.0% View Chart
Dividend Yield % 0.2 0.2 136.7%  

Financials

 IPCA LABS   J.B.CHEMICALS
EQUITY SHARE DATA
    IPCA LABS
Mar-17
J.B.CHEMICALS
Mar-16
IPCA LABS/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs643318 202.1%   
Low Rs503200 252.0%   
Sales per share (Unadj.) Rs254.4148.0 171.9%  
Earnings per share (Unadj.) Rs16.119.1 84.2%  
Cash flow per share (Unadj.) Rs29.823.9 124.3%  
Dividends per share (Unadj.) Rs1.000.50 200.0%  
Dividend yield (eoy) %0.20.2 90.3%  
Book value per share (Unadj.) Rs194.6128.9 150.9%  
Shares outstanding (eoy) m126.2084.82 148.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.31.7 128.8%   
Avg P/E ratio x35.713.6 262.9%  
P/CF ratio (eoy) x19.210.8 178.0%  
Price / Book Value ratio x2.92.0 146.7%  
Dividend payout %6.22.6 237.5%   
Avg Mkt Cap Rs m72,30021,951 329.4%   
No. of employees `00013.32.7 486.6%   
Total wages/salary Rs m6,9601,841 378.0%   
Avg. sales/employee Rs Th2,413.54,590.9 52.6%   
Avg. wages/employee Rs Th523.2673.4 77.7%   
Avg. net profit/employee Rs Th152.4592.1 25.7%   
INCOME DATA
Net Sales Rs m32,10612,551 255.8%  
Other income Rs m226542 41.7%   
Total revenues Rs m32,33213,093 246.9%   
Gross profit Rs m4,4482,055 216.5%  
Depreciation Rs m1,730412 419.4%   
Interest Rs m24196 251.6%   
Profit before tax Rs m2,7032,088 129.5%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m675469 143.9%   
Profit after tax Rs m2,0281,619 125.3%  
Gross profit margin %13.916.4 84.6%  
Effective tax rate %25.022.5 111.2%   
Net profit margin %6.312.9 49.0%  
BALANCE SHEET DATA
Current assets Rs m17,3407,778 222.9%   
Current liabilities Rs m9,5594,358 219.4%   
Net working cap to sales %24.227.2 88.9%  
Current ratio x1.81.8 101.6%  
Inventory Days Days10055 183.5%  
Debtors Days Days5780 71.1%  
Net fixed assets Rs m20,7795,713 363.7%   
Share capital Rs m252170 148.8%   
"Free" reserves Rs m24,49910,547 232.3%   
Net worth Rs m24,55310,937 224.5%   
Long term debt Rs m3,5170-   
Total assets Rs m39,59515,574 254.2%  
Interest coverage x12.222.8 53.6%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.80.8 100.6%   
Return on assets %5.711.0 52.1%  
Return on equity %8.314.8 55.8%  
Return on capital %10.520.0 52.5%  
Exports to sales %48.648.7 99.8%   
Imports to sales %14.27.1 201.1%   
Exports (fob) Rs m15,6176,115 255.4%   
Imports (cif) Rs m4,571889 514.3%   
Fx inflow Rs m15,6176,169 253.2%   
Fx outflow Rs m5,8281,285 453.5%   
Net fx Rs m9,7904,884 200.4%   
CASH FLOW
From Operations Rs m2,7641,397 197.9%  
From Investments Rs m-1,432-320 447.0%  
From Financial Activity Rs m-1,591-1,196 133.1%  
Net Cashflow Rs m-259-102 253.0%  

Share Holding

Indian Promoters % 45.9 55.4 82.9%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 11.4 3.4 336.3%  
FIIs % 25.3 3.9 648.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 37.0 47.0%  
Shareholders   36,892 30,437 121.2%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   STRIDES SHASUN LTD  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare IPCA LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Tata Stocks in Focus(09:30 am)

Asian stock indices are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.13% while the Hang Seng is down 0.54%. The Shanghai Composite is trading down by 0.02%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Aug 24, 2017 10:31 AM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS